Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (16,266,820)	$ (8,351,651)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	92,272	143,859
Share-based compensation expenses	584,991	880,789
Change in fair value of liability classified warrants	(9,298)	(499,138)
Allowance for bad debt		362,176
Warrant inducement expense	5,620,089
Changes in operating assets and liabilities:
Trade and other receivables	(95,215)	272,993
Prepaid expenses	(1,024,494)	(142,310)
ROU and other assets	24,537	39,643
Accounts payable and accrued expenses	(105,043)	(15,741)
Accrued severance and bonuses	2,186,555	135,686
Other current liabilities	5,508	(47,414)
Lease and other long term liabilities	(38,211)	(34,572)
Net cash used in operating activities	(9,025,129)	(7,255,680)
Cash flows from investing activities:
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from the sale of common stock and warrants, net	11,150,318	6,552,842
Proceeds from warrant exercises	3,547,894	236
Proceeds from short-term notes payable		414,320
Payments of short-term notes payable	(232,296)	(377,893)
Net cash provided by financing activities	14,465,916	6,589,505
Effects of exchange rates on cash	(1,185)	(6,018)
Net decrease in cash and cash equivalents	5,439,602	(672,193)
Cash and cash equivalents, beginning of year	5,114,917	5,787,110
Cash and cash equivalents, end of year	10,554,519	5,114,917
Supplemental cash flow information:
Cash paid for interest	$ 14,015	$ 8,920